two hundred three patients ( median age 26 years ; range 18-45 ) with untreated multiple and widespread anogenital condyloma were randomly assigned to one of four study arms in order to compare the efficacy , toxicity , and tolerability of recombinant interferon alpha-2b with those of diathermocoagulation .
C0009663
condyloma
C0021735
recombinant interferon alpha-2b